X4 Pharmaceuticals to Report Third-Quarter 2024 Financial and Phase 2 Chronic Neutropenia Study Results During Conference Call and Webcast on November 13, 2024

X4 Pharmicals10/24 12:00

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Is a Favorite Amongst Institutional Investors Who Own 51%

Yahoo Finance09/18 22:59

X4 Pharmaceuticals to Participate in Upcoming September Investor Conferences

newsfilter.io08/28 20:00

X4 Pharmaceuticals, Inc. (XFOR) Q2 2024 Earnings Call Transcript

Earnings Call Transcripts08/10 21:30

10-Q：Q2 2024 四半期報告書

SEC08/09 04:15

X4 Pharmaceuticals GAAP EPS of $0.45 Beats by $0.46

Seeking Alpha08/08 18:06